Hypersensitivity to irbesartan, hydrochlorothiazide and any other component of Co-Ivyzar.
Use in pregnancy: Drugs that act directly on the renin-angiotensin system can cause fetal and neonatal morbidity and death when administered to pregnant women. When pregnancy is detected, irbesartan should be discontinued as soon as possible.